# Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

> **NCT02576054** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 101 (actual)

## Conditions studied

- Anogenital Human Papilloma Virus Infection
- Condyloma Acuminata

## Interventions

- **BIOLOGICAL:** V501

## Key facts

- **NCT ID:** NCT02576054
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-20
- **Primary completion:** 2018-08-08
- **Final completion:** 2018-08-08
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576054, "Safety and Tolerability Study of V501 in Japanese Boys (V501-200)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02576054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*